JPS6291447A - Cement composition - Google Patents

Cement composition

Info

Publication number
JPS6291447A
JPS6291447A JP60231998A JP23199885A JPS6291447A JP S6291447 A JPS6291447 A JP S6291447A JP 60231998 A JP60231998 A JP 60231998A JP 23199885 A JP23199885 A JP 23199885A JP S6291447 A JPS6291447 A JP S6291447A
Authority
JP
Japan
Prior art keywords
agent
acid
cement composition
organic
cement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60231998A
Other languages
Japanese (ja)
Other versions
JPH0414583B2 (en
Inventor
一弘 小野
澁谷 睦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Showa Yakuhin Kako Co Ltd
Original Assignee
Showa Yakuhin Kako Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Yakuhin Kako Co Ltd filed Critical Showa Yakuhin Kako Co Ltd
Priority to JP60231998A priority Critical patent/JPS6291447A/en
Publication of JPS6291447A publication Critical patent/JPS6291447A/en
Publication of JPH0414583B2 publication Critical patent/JPH0414583B2/ja
Granted legal-status Critical Current

Links

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 セメント化し、長jlij間崩」又は脱落しないことを
特徴とするセメント2刃1成物に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a cement two-blade one-component which is cemented and is characterized by not collapsing or falling off.

従来の技術 1」腔又はmF・Fiil域におゆるのみならず外科、
成形外科、心医科において創傷面包帯剤として従来から
各錘のセメントd剤が用いられ、市販されてイル。これ
らの多くは酸化亜鉛とユーゾノールとを基本材料とし、
該セメントの強化剤としてはアスベスト繊維が使用され
ている。アスベスト繊維は【変化亜鉛及びユーゾノール
とのなじみが良くこれらの諸材料の凍相力の千″パ上で
のべトつきを抑える作用があると言われている。この性
質を利用した市販品が製剤化されている。
Conventional Technique 1: Not only surgery but also surgery in the cavity or mF・Fiil region.
Cement D agents of various weights have traditionally been used as wound dressings in plastic surgery and cardiac medicine, and are commercially available. Most of these use zinc oxide and euzonol as basic materials,
Asbestos fibers are used as reinforcing agents for the cement. Asbestos fibers are said to have a good compatibility with modified zinc and euzonol, and are said to have the effect of suppressing the stickiness of these materials when subjected to the freezing phase force.There are commercially available products that utilize this property. It has been formulated.

口腔内の1視n1x的手術は成形外科、口腔外科、歯科
の分野で日常数多く行なわれている。一例を上げれば成
形外科では口藷の奇形の手術、口腔外科では1」腔内癌
紐・虞の摘除術、顎骨に達するような手術、噛科ではI
l#+lミ術、歯肉切除術、歯(i除去、抜歯などがあ
る。
Intraoral 1-view n1x surgery is routinely performed in the fields of plastic surgery, oral surgery, and dentistry. For example, in plastic surgery, surgery for malformations of the mouth, in oral surgery, removal of intracavitary tumor cords, surgery that reaches the jawbone, and in occlusal medicine, I
Includes l#+lmi surgery, gingivectomy, tooth (i removal, tooth extraction, etc.).

口腔はその生活機能から云って常に唾液で濡れており、
食′吻を噛み砕き、会話をする↓に卯な器官であって史
に多揮多畦の細し胃が常圧する。かような部位の術後に
は19リえば抜Ii!!鎌の創傷面のように綿球で圧迫
させて市II′11シ、自然治癒させる場合もあれば、
歯石除去後の創傷面のようにヨード剤のような消毒請を
用いて貼薬して.轍者を帰宅させる場合もある。しかし
創傷面が大きく深い時で、しかも通常の生活を営みなか
ら則t4而の回復を第1る場合などには口腔内で固化す
る特別なセメントが使われることが多い。
Due to its daily functions, the oral cavity is always wet with saliva.
It is an organ that chews food and has conversations, and its thin stomach, which has many ridges and is known to be a rabbit, has a normal pressure. After surgery in such areas, 19 ri should be removed! ! In some cases, the wound may be compressed with a cotton ball like the wound surface of a sickle, and it may heal naturally.
Apply a disinfectant such as iodine to the wound surface after removing tartar. In some cases, people who are in a rut may be sent home. However, when the wound surface is large and deep, and when the primary objective is to recover from normal life, a special cement that hardens in the oral cavity is often used.

このセメントは施用時には粘Lのように軟らかく可塑性
があり、「1腔内では水分と77rA度とで硬化反応が
加速され数分で1.■1ヒし、創傷面を置い包む。
When applied, this cement is as soft and plastic as viscous L, and the hardening reaction is accelerated by moisture and 77 rA degrees within the first cavity, and it hardens in a few minutes, wrapping the wound surface.

このセメントをパック削とか包帯剤とか称する。This cement is called pack shavings or bandage.

あって該パックは扮木と液剤とが組になっており、粉末
は酸化亜鉛を主体とし、液剤はユーノノール(オイダノ
ール)を主体とするいわゆる酸化亜鉛ユージノールセメ
ントの一種である。該ノ9ツクの![¥徴は粉末の方に
処方されたアスベスト^裁維にあり、該繊維は練和から
施用に至るまでの取扱い操rμ一トに不iiJ欠の成分
であり、かつ、セメントが硬化した陵にはセメントの実
質をつなぐ「つなぎ材」の役目を持ち、口腔内で強靭性
を(呆持し開放創傷1mが治癒するまで破断されること
な(包帯剤として患部を覆う役目を4Hう。
The pack is made up of a combination of wood and a liquid agent, the powder mainly consisting of zinc oxide, and the liquid agent being a type of so-called zinc oxide eugenol cement mainly consisting of eunonol (eudanol). Of those 9! [This is because the asbestos fiber is formulated as a powder, and the fiber is an ingredient that cannot be handled in all steps from kneading to application, and the cement is hardened. It has the role of a ``tether'' that connects the substance of the cement, and maintains its toughness in the oral cavity so that it will not break until the open wound has healed.

上述のアスベスト繊維の役目である操作性と靭性との賦
与のうち後者は他の繊維即ち綿、ナイロン.春ロン、ア
クリル等いずれでも成程度の代用が可能であるが、前者
の操作性は微妙な感触の開−であって,従来はアスベス
トでなければ達成されないものとされていた。
Of the above-mentioned roles of asbestos fibers, which are to provide operability and toughness, the latter is achieved by other fibers such as cotton, nylon, etc. Although spring iron, acrylic, etc. can be used as substitutes to some extent, the operability of the former requires a delicate feel, which was conventionally thought to be achieved only with asbestos.

該操作性を説明すれば、術者が先ず粉末と液剤との適量
を採りス・母チュラで練和してイーストを作り該ペース
トをスiJ?チュラで転がし、沖ばして径!fin.長
さ4tcm位の円柱状にする。この操作でアスベストを
配合していないと円柱状にならず、該ペーストはス・9
チユラや練合板にペタペタくっつき取扱いにくい。次に
術者は円柱状とした1,〈練和物を指でつまみ、口腔内
の+JI 1M面に当て、指先で平らに沖ばして創傷面
の上を完全に情う。術者が指で練和物を取扱うときにペ
タペタと手J1に粘着したのでは創傷面に練和物を貼着
させることが困難である。このよ5に術者の使いやすい
包帯剤、即ち操作性のよい包帯剤はアスベストの配合に
より達せられることが知られており、又アスベスト以外
の繊維ではこの操作性を代行せしめることが出来ないも
のとされて来た。
To explain the operability, the operator first takes an appropriate amount of the powder and liquid, mixes it with a spoon, makes yeast, and mixes the paste with the paste. Roll it with a chula, push it off the coast and make a diameter! fin. Shape into a cylinder with a length of about 4tcm. If asbestos is not mixed in this operation, the paste will not become cylindrical, and the paste will be
It is difficult to handle as it sticks to the tumbler or plywood board. Next, the surgeon picks up the cylindrical mixture with his fingers, applies it to the +JI 1M surface in the oral cavity, and spreads it flat with his fingertips to completely cover the wound surface. If the mixture sticks to the hand J1 when the operator handles the mixture with his fingers, it is difficult to apply the mixture to the wound surface. It is known that a dressing that is easy for the operator to use, that is, has good operability, can be achieved by combining asbestos, and fibers other than asbestos cannot provide this operability. It has been said that

しかるに近時アスベストが人体に悪影響を績えることが
問題になり従ってこれに代るものが要望されると同時に
従来以上に口腔軟組櫓及び歯質並びにその他の組織の表
面への耐着性の向上及び長時間の局所滞留性の改善が求
められている。
However, in recent years, it has become a problem that asbestos has an adverse effect on the human body, and there is therefore a demand for an alternative to it. Improvement in long-term local retention is required.

問題点を解決するための手段 本発明に従えば上記の諸点に鑑みより改善されたセメン
ト組成物を得るために従来のセメント組成物中のアスベ
ストをノ9ルfl&雄で代替して混和し、さらにカルブ
キシビニル$ IJ −r −(以下CVPと略記)を
混合する。かようにして得られる新規なセメント組成物
は歯肉或いは歯質に粘着し易く、しかも従来以上に局所
滞留性が長時間に延長され、脱落又は崩壊し3いもので
あると同時にその製造が容易でコストも低いので組織表
面及び創傷面に対する包帯剤として最適である。
Means for Solving the Problems According to the present invention, in view of the above points, in order to obtain an improved cement composition, asbestos in the conventional cement composition is substituted and mixed with No. Furthermore, carboxyvinyl $ IJ -r - (hereinafter abbreviated as CVP) is mixed. The novel cement composition obtained in this manner easily adheres to the gums or tooth structure, has a longer local retention than before, is resistant to falling off or disintegrating, and is easy to manufacture. Due to its low cost, it is ideal as a dressing for tissue and wound surfaces.

本発明の特徴は従来から知られている酸化亜鉛、ユージ
ノール、アスベスト繊維 、及び有機飽和Ha脂肪酸は
有機不飽和脂肪酸で溝成されるセメント組成物中のアス
ベスト繊維の代りにパルプ繊維を混和し、さらに軟組織
及び歯質又は創傷の表面への付着性、施用後の早期の脱
落並びにセメント実質の崩壊性を改善するためにCVP
を混合することにある。アスベストを加えないで製した
酸化gi鉛とユージノールとからなるセメント組成物は
これを創傷面纏帯剤として使用すると練和物は手指にペ
タペタ粘着するため該練和物を手掌上でメンf状にまる
める際にノμ粛な困aを伴なうなどの欠点をもつ。
The characteristics of the present invention are that the conventionally known zinc oxide, eugenol, asbestos fibers, and organic saturated Ha fatty acids are mixed with pulp fibers in place of asbestos fibers in a cement composition composed of organic unsaturated fatty acids; Furthermore, CVP is used to improve adhesion to soft tissues and tooth surfaces or wound surfaces, early shedding after application, and disintegration of cement parenchyma.
It consists in mixing. When a cement composition made of gi-lead oxide and eugenol made without adding asbestos is used as a wound dressing, the mixture sticks to the hands and fingers, so it is difficult to apply the mixture on the palm of the hand. It has disadvantages such as the difficulty of rounding it up.

本発明では酸化亜鉛を主体とする^剤と、ユージノール
又は有機酸を含有するB剤とからなり、使用時に^剤及
び8剤を適才混相して患部に施用するが繊維は通常A剤
中に処方されるので、先ず、本発明においてもへ剖につ
いて検討した。その結果該セメント組成物の^剤中の従
来のアスベストの代りにノ9ルデ嘩雄な混和すると該セ
メント硬化物(以下セメント体と略記する)の強度を向
上し併せてCVPの添加混合により該セメント体の組織
又は歯肉の表面への粘着性が向上し、該セメント体の脱
落及び崩壊が著しく改善され長期間の使用が可能となっ
た。
In the present invention, the agent consists of an agent mainly containing zinc oxide and an agent B containing eugenol or an organic acid, and when used, the agent and agent 8 are appropriately mixed and applied to the affected area, but the fiber is usually included in agent A. Since it is prescribed, we first examined autopsy in the present invention. As a result, when asbestos is mixed in place of the conventional asbestos in the cement composition, the strength of the hardened cement product (hereinafter abbreviated as cement body) is improved. The adhesion of the cement body to the tissue or gingival surface has been improved, and the shedding and disintegration of the cement body have been significantly improved, making it possible to use it for a long period of time.

この場合にパルプ繊維の代りに油の准維としてナイロン
、ビニロン、又はテトロン繊維を使用したがノ4ルゾ繊
維程の効果を達成することができなかった。これは、4
ルゾ繊維が綿繊維を切断して製造されたものでありまた
繊維構成分のグルコース分子面の遊離の一〇H基及び−
〇HO基 等の親木性基の存在のため該B剤との親和性
と同時に該B剤に対して繊維のもつ物理的な護持性を呈
するのでこれらの性質がセメント練和物の靭性の確保及
び術者の手指にペタペタ付着しないという特性に寄与し
ていると考える。
In this case, nylon, vinylon, or tetron fibers were used as oil fibers in place of pulp fibers, but they could not achieve the same effect as 4-Ruso fibers. This is 4
Luso fibers are produced by cutting cotton fibers, and include free 10H groups and -
O Due to the presence of wood-philic groups such as HO groups, the fibers have an affinity for the B agent and at the same time exhibit the physical protective properties of the fibers for the B agent, so these properties affect the toughness of the cement mix. We believe that this contributes to the property of securing the adhesive and not sticking to the surgeon's fingers.

また他方CVPについてはこのものは前記の通りアクリ
ル酸とアリル化多両アルコールとの共重合によって得ら
れた水溶性高分子であり従来から化粧品及び医薬品等の
増粘剤又は分散安定剤として知られ【いるが歯科静のセ
メント組成物に使用された例は本発明以前にない。例え
ば水溶性高分子とVP程の効果は得られなかった。これ
はCVPは分子内のOH基及びC0OH基の存在により
該セメント組成物中の強力な界面活性剤として作用し従
って該組成物相互の親和性を増すと共に唾液と遭遇し、
セメント体表面の粘性を増し生体組織との親和性を向上
させる結果として組1表面或は歯質又は歯肉表面に対す
る粘着力を増し、該ノ4ルーf@維の作用と相喚って該
セメント体の特性を改善向上せしめるのであると考えら
れる。
On the other hand, as mentioned above, CVP is a water-soluble polymer obtained by copolymerizing acrylic acid and allylated polyalcohol, and has been known as a thickener or dispersion stabilizer for cosmetics and pharmaceuticals. [However, there have been no examples of its use in dental cement compositions prior to the present invention. For example, it was not as effective as water-soluble polymer and VP. This is because CVP acts as a strong surfactant in the cement composition due to the presence of OH and COOH groups in the molecule, thus increasing the affinity of the composition for each other and encounter with saliva.
As a result of increasing the viscosity of the surface of the cement body and improving its affinity with living tissue, the adhesion to the surface of the group 1 or tooth substance or gingival surface increases, and in interaction with the action of the 4-4 fibers, the cement It is thought that it improves the characteristics of the body.

更にCVPに代用し得られるものについて4々研究の結
果4ルミチン酸及びステアリン酸等の有機脂肪酸がCV
Pに近い効果を示すことを見出した。本発明においてC
VPの代替物として又はCvpとの併用物としてのへ剤
中の有機脂肪酸はラウリン酸、ミリスチン酸、ノ臂ル建
チン酸及びステアリン酸で、常温で固型の脂肪酸である
。これらの有機脂肪酸は分子中に−COOHAを持って
おり、この点はcypが分子中に一〇〇〇H基を有する
のと共通である。有+* ray肪酸の−CH2−は疎
水性であるが、−COOH基は親水性であり、該セメン
ト体表面と生体組織との親和性を増すために、結果とし
てCVPを用いたと同様に該セメント体の特性を改善向
上せしめるのであると考えられる。
Furthermore, as a result of 4 studies on substances that can be substituted for CVP, 4 organic fatty acids such as lumitic acid and stearic acid are substituted for CVP.
It was found that the effect was similar to that of P. In the present invention, C
The organic fatty acids in the hemolymph as a substitute for VP or used in combination with Cvp are lauric acid, myristic acid, nolactic acid, and stearic acid, which are solid fatty acids at room temperature. These organic fatty acids have -COOHA in their molecules, which is common to cyp, which has a 1000H group in its molecules. -CH2- of the ray fatty acid is hydrophobic, but the -COOH group is hydrophilic, and as a result, in order to increase the affinity between the cement surface and living tissue, similar to the use of CVP. It is believed that this improves the properties of the cement body.

なおまたパルプ繊維は該セメント組成物のA剤中、2〜
7重縫平縫和されることが望ましく、又CVP及び(又
は)有機脂肪酸は該セメント組成物の^剤中a/〜3θ
重t%の量で混合されることが好ましい。
In addition, pulp fibers are included in the A agent of the cement composition.
It is preferable that the cement composition is sewn with 7 layers of plain stitches, and CVP and/or organic fatty acids are included in the agent of the cement composition.
Preferably, they are mixed in an amount of t% by weight.

次にB剤についてはこれはユージノール及びオリ!油か
らなり、ユージノールはjθ〜7 j−1i ti%、
オリブ油は20〜70重量%が適当であり、有機脂肪酸
はその炭素数が10〜2.2で一般弐〇nH2n+IC
0OHr Cn’zn−ICOOH,CnH2n−gc
OOH及びCnH2n 5 C0OHの何れかに相当す
る有機飽和または不飽和脂肪酸であり、その他プロピレ
ングリコール、ポリアルキレングリコールもB副成分と
して使用されることができる。さらにこれらのダリコー
ル化合物の混合物も使用され得る。
Next, regarding agent B, this is Eugenol and Ori! consisting of oil, eugenol jθ~7 j−1i ti%,
The appropriate amount of olive oil is 20 to 70% by weight, and organic fatty acids have a carbon number of 10 to 2.2 and are generally 2〇nH2n+IC.
0OHr Cn'zn-ICOOH, CnH2n-gc
It is an organic saturated or unsaturated fatty acid corresponding to either OOH or CnH2n 5 C0OH, and propylene glycol and polyalkylene glycol can also be used as the B subcomponent. Additionally, mixtures of these dalicol compounds may also be used.

ユージノール(オイrノール)は丁字油の主成分(通常
70%以上を含む)であるが、日本薬局方丁字油はユー
ジノール及び関連化合物を含め総オイrノールとしてg
θ%以上を含縫規格としている。本発明においてユージ
ノールは上記局方丁字油とはほとんど同一の物質とみな
されて本発明の製品を製することができる。
Eugenol (oil-nol) is the main component of clove oil (usually containing 70% or more), but Japanese Pharmacopoeia clove oil contains eugenol and related compounds as a total oil-nol.
θ% or more is considered as a standard for inclusion of seams. In the present invention, eugenol is considered to be almost the same substance as the above-mentioned pharmacopoeia clove oil, and the product of the present invention can be manufactured.

以上本発明のセメント組成物の特異成分について詳述し
たが該セメント組成物の製造は実施例に示すように先ず
仕込量の^剤各組成分を秤縫しこれを粉砕した後に攪拌
機で混和しほぼ一礪の混相物(粉体)にしてから製せら
れる。B削はB #11成分を秤(止したものを州庁に
混合し【全体(液体)が均一になれば充分である。使用
時に術者は^剤とB剤との適量をとり、凍相して患部に
対して使用する。
The specific components of the cement composition of the present invention have been described in detail above, but as shown in the examples, the cement composition is manufactured by first weighing the charged amount of each component of the agent, pulverizing it, and then mixing it with a stirrer. It is manufactured after being made into approximately one batch of mixed phase material (powder). For B shaving, B #11 is weighed and mixed in the state office [it is sufficient if the whole (liquid) is uniform.When using, the operator takes an appropriate amount of agent ^ and agent B, and freezes it. Use at the same time on the affected area.

一夾−箒性 一何−J (^ 剤) (重It%)  (8剤)(41%)酸化
亜鉛    5!r   丁 字 油   7!rロゾ
ン   コS  オリゾ油  コIA3ケイソウ土  
 /S   ゾロビオ/酸  aSノ臂ルア°&a雄 
         1CVP       / ロジン塊を予め10メシ工程度に粉砕し、この粉砕ロジ
ン。25匈及び酸化亜鉛5ぶゆを混相して微粉砕する。
Ichikyo - Houkisei Ichika - J (^ Agent) (Heavy It%) (8 agents) (41%) Zinc oxide 5! r T letter oil 7! rRozone KoS Oryzo oil KoIA3 diatomaceous earth
/S Zorobio/Acid aS arm Lua ° & a male
1 CVP/Rosin lump is pre-pulverized to 10 mesh steps, and this crushed rosin is obtained. A mixture of 25 tons and 5 tons of zinc oxide was mixed and pulverized.

該粉砕・吻に対しケイツク土/!;に9、・IルアQ繊
維pb及びcVP/に#を加えて贋速度で混合し^剤を
製した。B剤についてはT字油7j匈、オリ!油、2名
5kg及びプロピオン酸θ、8′ユを秤取し混合して8
剤を製した。
Keitsuku earth/! against the crushing and snout! To 9, # was added to I Lua Q fiber pb and cVP/ and mixed at a slow speed to prepare a preparation. As for agent B, T-shaped oil 7j, ori! Weigh out 5 kg of oil for 2 people and 8' y of propionic acid and mix them to make 8
A drug was prepared.

本例の製品は歯科、口腔外科のみならず外科、成形外科
、獣医科等において好適に使用され得る。
The product of this example can be suitably used not only in dentistry and oral surgery, but also in surgery, plastic surgery, veterinary medicine, and the like.

−例  λ (^  剤)(重祉%)   (B   剤) (、X
¥Jk% )酸化亜鉛    60    丁 字 油
  ASロ ゾ ン   −左    オリゾ油  3
左ノ量ルア#繊維    7 CVP    O,コ 例/に準じて酸化亜鉛6θkg及びロジン25ゆを混和
した粉砕物を製し、これに対しステアリン酸マグネシウ
ム7gl<g、ノ9ルflam’7ゆ及びcvPQ2k
gを加えて^剤を製した。
-Example λ (^ agent) (heavy welfare%) (B agent) (,X
¥Jk%) Zinc oxide 60 T-shaped oil AS Lozone -Left Oryzo oil 3
A pulverized product was prepared by mixing 6θ kg of zinc oxide and 25 kg of rosin according to Example 7 of Lua #Fiber on the left, and 7 g of magnesium stearate, 7 g of magnesium stearate, and 7 g of magnesium stearate. cvPQ2k
g was added to prepare a ^ agent.

B刑についても例/の方法に準じ、T字油乙jkg及び
オリゾ油35ゆを混合しB剤を製した。
As for B, agent B was prepared by mixing 1 kg of T-shaped oil and 35 kg of Oryzo oil according to the method in Example/.

例22ノ (A  剤)(重;10  (B  削)(実1日酸化
匝鉛    左N  ユージノール   乙θロゾン 
   3θ  オリブ油    lIOケイソウ土  
 /θ )9ルゾ繊維    ダ ステアリン酸   / 例/に皐じて酸化亜鉛&、!rkg及びロジン30に9
を混和した粉砕物を製し、これに対しケイソー士/ O
kg、パルf積維lIV及びステアリン酸/ゆを加えて
へ剤を製した。B剤についても例/の方法ニ準じユージ
ノール6θkg及びオリブ油グθkflを混合しB剤を
製した。
Example 22 (A agent) (weight; 10 (B shaved) (Actual 1 day lead oxide left N Eugenol Otsu θ Lozone
3θ Olive oil lIO diatomaceous earth
/ θ ) 9 Luso fibers Dastearic acid / Example / Zinc oxide &,! rkg and rosin 30 to 9
A pulverized product is prepared by mixing the
kg, Parf fiber lIV and stearic acid/yu were added to prepare a gelatin. For agent B, 6θ kg of eugenol and θkfl of olive oil were mixed to prepare agent B according to the method in Example.

例  ダ (^ 剤)(創0)  (日 剤)(1%)酸化亜鉛 
   !f&    リノールe   、20μシン 
     20   イソステアリン酸 30ノ昔ルデ
繊禮   lA左 CVP       O,!r 例/に準じて酸化唾鉛S左ゆ及びロジン20kgを混相
した粉砕物を製し、これに対しケイソウ土−〇kg、パ
ルプ繊維グS時及びCVPθ左ゆを加えて^剖を製した
。8削についても例/の方法に準じリノール酸aθkg
、イソステアリン酸30kl及びプロピレングリコール
左θkgを混合しB剤を製した。
Example Da (^ agent) (wound 0) (day agent) (1%) zinc oxide
! f & linole e, 20μ thin
20 Isostearic acid 30 years ago Rude fiber lA left CVP O,! According to Example/, a pulverized product was prepared by mixing 20 kg of oxidized salivary lead S and rosin, and to this, diatomaceous earth -〇kg, pulp fiber G S and CVPθ were added to prepare a pulverized product. . For 8 cuts, follow the method in Example/ linoleic acid aθkg
, 30 kl of isostearic acid and θ kg of propylene glycol were mixed to prepare Form B.

例  、9 (A   剤)ltkt%)   (B  剤)(ff
iii1%)酸化亜鉛    lIOリノール酸   
左0パル7″繊m    左 CVP       3 例/に準じて酸化亜鉛りθゆ及びロジン110kgを混
相した粉砕物を製し、これに対しケイソウ土/、2#s
ノ+ルゾ繊維Skg及びc v p 3vを加えて^剤
を製した。B剤についてはリノール酸左oH及びゾロピ
レングリコールsokgを秤取し混合してB剤を製した
Example, 9 (A agent) ltkt%) (B agent) (ff
iii1%) Zinc oxide lIO linoleic acid
Left 0 Pal 7″ fiber m Left CVP 3 According to Example/, a pulverized product was prepared by mixing 110 kg of zinc oxide resin and rosin, and to this, diatomaceous earth/, 2#s
Nor+Ruso fiber Skg and cvp 3v were added to prepare a ^ agent. As for the B agent, linoleic acid (OH) and zoropylene glycol (sokg) were weighed out and mixed to prepare a B agent.

例  ル (A 剤)(引u%)   (B  剤)(重1%)酸
化亜鉛    左Oユージノール  6Sロゾン   
  、2g   オリゾ油   3’A!fケイソウ土
   /S   ゾロピオン酸  o、Sパルプ1雄 
   左 CVP        / qリスチン酸   / 例1に準じて酸化亜鉛!θkg及びロジン2gkl/を
混和した粉砕物を製し、これに対しケイソウ土/!に4
1、/f yv ′:j′m維gkg、 c v P 
/に?及ヒi リスチン酸lゆを加えて^剤を製した。
Example (A agent) (U%) (A agent B) (wt 1%) Zinc oxide Eugenol 6S Rozone
, 2g oryzo oil 3'A! f diatomaceous earth /S zolopionic acid o, S pulp 1 male
Left CVP / qlistic acid / Zinc oxide according to Example 1! A pulverized product was prepared by mixing θkg and rosin 2gkl/, and diatomaceous earth/! to 4
1, /f yv ′:j′m fiber gkg, c v P
/to? A preparation was prepared by adding listic acid.

B剤についても列lの方法に準じ、ユージノール63ゆ
、オリゾ油3’ASJ及びノロピオン酸θ左ゆを混合し
B剤を製した。
For agent B, Eugenol 63, Oryzo oil 3'ASJ, and Noropionic acid θ were mixed to prepare agent B according to the method in column 1.

発明の効果 以上の各実施例において製造された^削(散剤)及びB
剤(液剤)を適数ずつ練和して得られる練和物は口腔内
のみならず外科、成形外科、獣医科等の他の領域におけ
る湿貞した創傷面に付着しやすく、セメント体(硬化物
)は長時fijlJ局所に安定して滞留することにより
*’s’J’Qk面の保護に十分な効果な奏することが
期待される。
The ^ shavings (powder) and B produced in each example above the effect of the invention
The mixture obtained by kneading an appropriate number of agents (liquid agents) easily adheres not only to the oral cavity but also to wet wound surfaces in other fields such as surgery, plastic surgery, veterinary medicine, etc. It is expected that by stably staying locally in the fijlJ region for a long period of time, it will be sufficiently effective in protecting the *'s'J'Qk surface.

又本製剤の組成物中にはアスベストを含まないため人体
への安全性も高い。又本発明のセメント組成物はその製
造が容易で製品コストも低廉である。
Furthermore, since the composition of this preparation does not contain asbestos, it is highly safe for the human body. Furthermore, the cement composition of the present invention is easy to manufacture and the product cost is low.

Claims (5)

【特許請求の範囲】[Claims] (1)酸化亜鉛35〜60重量%、ロジン20〜40重
量%、ケイソウ土10〜20重量%、カルボキシビニル
ポリマー及び(又は)有機脂肪酸0.1〜3.0重量%
を粉砕し、これにパルプ繊維2〜7重量%を混合して製
した一般に粉状をなすA剤と一般に液状をなすB剤とか
らなる組成物であること、及び該A剤に対しB剤を加え
て練合わせた練和物がセメント化することを特徴とする
セメント組成物。
(1) Zinc oxide 35-60% by weight, rosin 20-40% by weight, diatomaceous earth 10-20% by weight, carboxyvinyl polymer and/or organic fatty acid 0.1-3.0% by weight
The composition consists of a generally powdered agent A and a generally liquid agent B, which are prepared by pulverizing and mixing 2 to 7% by weight of pulp fibers, and A cement composition characterized in that a kneaded mixture with the addition of is turned into cement.
(2)カルボキシビニルポリマーがアクリル酸とアリル
化多価アルコールとの共重合体である特許請求の範囲第
1項記載のセメント組成物。
(2) The cement composition according to claim 1, wherein the carboxyvinyl polymer is a copolymer of acrylic acid and an allylated polyhydric alcohol.
(3)A剤中の有機脂肪が一般式C_nH_2_nCO
OHに相当する有機飽和脂肪酸(但しn=10〜22)
である特許請求の範囲第1項記載のセメン ト組成物。
(3) The organic fat in agent A has the general formula C_nH_2_nCO
Organic saturated fatty acids corresponding to OH (however, n=10-22)
The cement composition according to claim 1.
(4)A剤中の有機脂肪酸が常温で固体の脂肪酸であり
、ラウリン酸、ミリスチン酸、パルミチン酸及びステア
リン酸からなる群から選ばれる特許請求の範囲第3項記
載のセメント組成物。
(4) The cement composition according to claim 3, wherein the organic fatty acid in agent A is a fatty acid that is solid at room temperature and is selected from the group consisting of lauric acid, myristic acid, palmitic acid, and stearic acid.
(5)B剤がユージノール又は丁字油;炭素数10〜2
2の一般式C_nH_2_n_+_1COOHに相当す
る有機飽和脂肪酸;C_nH_2_n_−_1COOH
、C_nH_2_−_3COOHC_nH_2_n_−
_5COOHのいずれかに相当する有機不飽和脂肪酸;
プロピレングリコール、ポリアルキレングリコール、又
はこれらのグリコール化合物の混合物;及びオリブ油か
らなる群から選ばれる成分を含有する特許請求の範囲第
1項記載のセメント組成物。
(5) B agent is eugenol or clove oil; carbon number 10-2
Organic saturated fatty acid corresponding to the general formula C_nH_2_n_+_1COOH of 2; C_nH_2_n_-_1COOH
, C_nH_2_-_3COOHC_nH_2_n_-
_Organic unsaturated fatty acids corresponding to any of 5 COOH;
The cement composition according to claim 1, containing a component selected from the group consisting of propylene glycol, polyalkylene glycol, or a mixture of these glycol compounds; and olive oil.
JP60231998A 1985-10-17 1985-10-17 Cement composition Granted JPS6291447A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60231998A JPS6291447A (en) 1985-10-17 1985-10-17 Cement composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60231998A JPS6291447A (en) 1985-10-17 1985-10-17 Cement composition

Publications (2)

Publication Number Publication Date
JPS6291447A true JPS6291447A (en) 1987-04-25
JPH0414583B2 JPH0414583B2 (en) 1992-03-13

Family

ID=16932340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60231998A Granted JPS6291447A (en) 1985-10-17 1985-10-17 Cement composition

Country Status (1)

Country Link
JP (1) JPS6291447A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240713A (en) * 1990-02-15 1991-10-28 Nippon Oil & Fats Co Ltd Dental cement-curing solution
JPWO2008035816A1 (en) * 2006-09-21 2010-01-28 俊樹 大黒 Hard tissue regeneration promoter
JP2010105953A (en) * 2008-10-30 2010-05-13 Bee Brand Medico Dental Co Ltd Dental composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240713A (en) * 1990-02-15 1991-10-28 Nippon Oil & Fats Co Ltd Dental cement-curing solution
JPWO2008035816A1 (en) * 2006-09-21 2010-01-28 俊樹 大黒 Hard tissue regeneration promoter
JP5557448B2 (en) * 2006-09-21 2014-07-23 俊樹 大黒 Hard tissue regeneration promoter
JP2010105953A (en) * 2008-10-30 2010-05-13 Bee Brand Medico Dental Co Ltd Dental composition

Also Published As

Publication number Publication date
JPH0414583B2 (en) 1992-03-13

Similar Documents

Publication Publication Date Title
Hill Dental cements for definitive luting: a review and practical clinical considerations
US4235633A (en) Dental compositions
DE60206561T2 (en) Dental cement composition
US3219527A (en) Peridontal pack or dressing composition
EP1258239B1 (en) Chemically-curing dental bleaching composition
DE112006003909B4 (en) adhesive system
WO1994023687A1 (en) Preformed glass ionomer filler which can sustainedly release fluoride ion and dental composition containing the same
KR20140042749A (en) Polymerizable compositions
JPS6310128B2 (en)
CN111163744B (en) Fluorine coating agent having improved dentinal tubule penetration and coating retention and method for preparing the same
Johnson Root canal filling materials
JPS6291447A (en) Cement composition
JP2023159376A (en) Glass ionomer cement composition for dental luting with good removability
US5417750A (en) Dental or medical alginate impression material
Horn The cementation of crowns and fixed partial dentures
EP0534264B1 (en) Alginate impression material
JPH02311408A (en) Gel-like composition for skin
PL125420B1 (en) Paste for filling tooth-canals
JP6501189B2 (en) Dental curable composition and method for producing the same
Mhatre et al. Chemo-mechanical caries removal system-A brief review
JPS60181004A (en) Dental cement composition
JPH0585914A (en) Curing type paste material
DAHL Some biological considerations in crown and bridge prosthetics
JP4132809B2 (en) Glass ionomer sealer composition for root canal filling
JPH04230612A (en) Curing type paste for filling in root canal

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees